Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to...
Pulse Biosciences schedules second-quarter results conference call
Pulse Biosciences grants inducement stock options for 9,000 shares at USD 25.89 each
The Great Uncoupling: Defense Tech Thrives While Consumer Stocks Scramble
Cross-Sector Moves: Cisco's AI Push and Broad Capital Restructuring
Biotech Pipeline Accelerates: Inside Ginkgo Bioworks and Pulse Biosciences' Latest Moves
US Market’s Unclassified Tickers Highlight Shifting Global Supply Chains